Evidence map›Paper›PMID 37206388›Full record

ReviewChemical science2023

Aptamers 101: aptamer discovery and

Lucy F Yang, Melissa Ling, Nataly Kacherovsky, Suzie H Pun

Open access · diamondAbstract readReview
In one paragraph

Review in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. RNA chemistry and therapeutics.Nature reviews. Drug discovery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucy F YangDepartment of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington Seattle Washington USA spun@uw.edu.
Melissa LingDepartment of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington Seattle Washington USA spun@uw.edu.
Nataly KacherovskyDepartment of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington Seattle Washington USA spun@uw.edu.
Suzie H PunDepartment of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington Seattle Washington USA spun@uw.edu.ORCID https://orcid.org/0000-0003-1443-4996
University of Washington · US

Funding

Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2U01AA029316 · NIAAA · UNIVERSITY OF WASHINGTON · PI PUN, SUZIE H., SMITH, JOSHUA R · 2021 to 2022
$922k
NIAAA NIH HHS U01 AA029316
6 · The paper itself

Abstract

Aptamers are single-stranded nucleic acids that bind and recognize targets much like antibodies. Recently, aptamers have garnered increased interest due to their unique properties, including inexpensive production, simple chemical modification, and long-term stability. At the same time, aptamers possess similar binding affinity and specificity as their protein counterpart. In this review, we discuss the aptamer discovery process as well as aptamer applications to biosensors and separations. In the discovery section, we describe the major steps of the library selection process for aptamers, called systematic evolution of ligands by exponential enrichment (SELEX). We highlight common approaches and emerging strategies in SELEX, from starting library selection to aptamer-target binding characterization. In the applications section, we first evaluate recently developed aptamer biosensors for SARS-CoV-2 virus detection, including electrochemical aptamer-based sensors and lateral flow assays. Then we discuss aptamer-based separations for partitioning different molecules or cell types, especially for purifying T cell subsets for therapeutic applications. Overall, aptamers are promising biomolecular tools and the aptamer field is primed for expansion in biosensing and cell separation.

Identifiers

PMID37206388
PMCPMC10189874
OpenAlexW4367728926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.